본문 바로가기
  • New Standard of
    Tissue Dissociation Enzyme


    Recombinant tissue dissociation enzymes
    individually contained in a smart device



  • Recombinant collagenase originating from Clostridium histolyticum
  • Chromatographically purified enzyme
  • Innovative packaging

Recombinant tissue dissociation enzyme


Genetic engineering is used to secure animal source free condition.

  • Collagenase class I (collagenase G) originating from Clostridium histolyticum

  • Collagenase class II (collagenase H) originating from Clostridium histolyticum

  • Thermolysin originating from Geobacillus stearothermophilus

Purified & blended type enzyme (not crude type)

  • Highly purified using column chromatography technology

  • Blended with three enzymes at fixed ratio

  • High lot-to-lot consistency

  • High purity & low endotoxin

Innovative packaging technology

  • Application of smart packaging technology providing higher user-friendly experiences than conventional vial packaging

  • Easy in-line sterile filtration to minimize microbial contamination during primary cell culture

Ordering information


TDzyme® TL Pack

  • Product No: TDL0010
  • Contents: TDzyme® C (5mg), 2ea

TDzyme® TM Pack

  • Product No: TDM0008
  • Contents: TDzyme® C (5mg) + TDzyme® T (3mg)
Ordering information
Product name Product No. Contents
TDzyme® TL Pack TDL0010 TDzyme® C (5mg), 2ea
TDzyme® TM Pack TDM0008 TDzyme® C (5mg) + TDzyme® T (3mg)
  • TDzyme® C (blue cap): Collagenase (including low level of thermolysin)
  • TDzyme® T (red cap): Thermolysin
  • Unlike crude type collagenases, TDzyme’s content expressed in mg indicates only that of purified tissue dissociation enzyme. Other ingredients such as buffer,
    stabilizer, and media components contained in crude type collagenases are excluded in TDzyme. In crude type collagenases, the proportion of contents of other
    ingredients are considerably high while the proportion of tissue dissociation enzyme is usually very low.

Distributor information



Contact us

For further information, please contact CONNEXT.

CONNEXT is a spin-off company of Korea Institute of Industrial Technology (KITECH), a Korean government funded
research institute, offering highly purified recombinant proteins in a smart device for tissue engineering,
cell isolation and primary cell research field.

Founded in 2017, Connext is a Korean clinical-stage biotechnology company spun-off from a
government-funded research institute. Connext aims to improve quality of life by rapidly delivering
innovative medicines and technologies to patients. Based on its current portfolio, TLR5 agonist and
collagenase, Connext is expanding indications to cover a wide range of diseases in the areas of
oncology, dermatology and chronic wound care. To achieve this, Connext is focused on finding
opportunities to connect and collaborate with partners globally.